Riyadh: Under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince, Prime Minister, and Chairman of the Board of Directors of the Riyadh Biocentral Foundation, the fourth edition of the Riyadh Global Medical Biotechnology Summit will be held from September 14 to 16. The summit is regarded as one of the world's leading international gatherings in the biotechnology sector, bringing together government leaders, decision-makers, chief executives of major pharmaceutical companies, experts, and investors in medical biotechnology, cell and gene technologies, and artificial intelligence in the life sciences.
According to Saudi Press Agency, the organization of the summit aligns with the objectives of Saudi Vision 2030, aiming to promote innovation, develop the bioeconomy, and attract high-quality investments in the pharmaceutical and advanced technology sectors. It also reflects the Kingdom's pivotal role in supporting biomedical research and leading global initiatives in public health and future technologies.